Jens-Peter Von Kries

Title: Jens-Peter Von Kries: Innovator in Cancer Treatment

Introduction

Jens-Peter Von Kries is a notable inventor based in Zepernick, Germany. He has made significant contributions to the field of molecular medicine, particularly in the development of treatments for human illnesses. His work focuses on innovative approaches to combat cancer through the manipulation of specific proteins.

Latest Patents

Jens-Peter Von Kries holds a patent titled "Agents for treating human illnesses based on β-catenin, and the production and use thereof." This invention relates to peptides that influence the interaction of the protein β-catenin with transcription factors or tumor suppressor proteins. The peptides are derived from amino acids known to interact with these proteins, aiming to inhibit the binding of β-catenin and the transcription factor or tumor suppressor protein. The invention also considers peptide mutants and peptidomimetic compounds, which are useful for treating cancer in mammals, particularly in humans. He has 1 patent to his name.

Career Highlights

Jens-Peter Von Kries is associated with the Max-Delbrück-Centrum für Molekulare Medizin, where he conducts his research. His work has been instrumental in advancing the understanding of cancer treatment methodologies.

Collaborations

He collaborates with notable colleagues in the field, including Walter Birchmeier, to further enhance the impact of his research.

Conclusion

Jens-Peter Von Kries is a pioneering inventor whose work in cancer treatment through the modulation of β-catenin interactions showcases the potential of innovative medical therapies. His contributions continue to influence the landscape of molecular medicine.